X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi

期刊標題檢索 UHOD-ULUSLAR HE 最新評論: Authors need to objectively assess whether the quality of their resear... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi]您好,您是該頁面的第 14065 位訪客。

期刊簡介
期刊名稱UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi
LetPub Score
5.0
50 ratings
Rate

Reputation
6.4

Influence
3.5

Speed
7.0

期刊簡稱UHOD-ULUSLAR HEMATOL
ISSN1306-133X
E-ISSN2412-8333
h-index9
CiteScore
CiteScoreSJRSNIPCiteScore Rank
0.090.1090.049
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Hematology
Q4113 / 122
Category: Medicine
Subcategory: Oncology
Q4291 / 321

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Target of Publication is the public representation of new scientific results of fundamental, problem-oriented, and search scientific investigations; analytical articles and reviews by actual scientific problems of coal mining industry, short reports in the field of coal mining industry, including the results of work of scientific meetings, conferences, summit’s and congresses in the field of mining. The basic purpose of the journal is the promotion of innovative activity in the coal mining industry by highlighting and discussing the results of basic and applied research, the experience in applying results of innovation for the development of the Russian coal mining.
The most important tasks of the journal are: the generalization of scientific and practical achievements of specialists in the field of coal mining industry, specializing in the implementation of promising basic and applied research and development of priorities of high technologies; the scientific concept of the publication; the publication of the latest achievements in the field of innovation in coal mining industry. The journal lays special emphasis on methodical elaborations, analytical investigations in the sphere of coal mining. Targets of Journal are in publication of new results of scientific investigations performed by scientists, post-graduate students, and doctoral candidates performed by from higher schools, Russian Academy of Sciences, other scientific organizations of Russia, CIS countries, and foreign universities
官方網站http://www.uhod.org/
在線稿件提交http://www.uhod.org/submit/login.php?page=0&nocache=c58f966664ccba67b6e94fb65e177fe0
開放訪問No
出版商UHOD - Uluslararasi Hematoloji Onkoloji Dergisi
主題領域ONCOLOGY
出版國/地區TURKEY
發行頻率四半期刊行
創刊年2006
每年文章數23每年文章數趨勢
黃金OA百分比50.00%
Web of Science 四分位
2023-2024
WOS Quartile: Q4

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ4309/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1306-133X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE640684
    BIOMATERIALS569249
    BIOMEDICINE & PHARMACOTHERAPY498318
    Frontiers in Pharmacology486581
    Journal of Materials Chemistry B476053
    JOURNAL OF ETHNOPHARMACOLOGY475384
    Frontiers in Immunology457830
    COLLOIDS AND SURFACES B-BIOINTERFACES419204
    COMPUTERS IN BIOLOGY AND MEDICINE416220
    Frontiers in Oncology413337
  •  

    UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 18:23:49 評論於
Authors need to objectively assess whether the quality of their research work matches the level of the selected journal. Top journals have high demands for the originality of manuscripts. The acceptance rate of top journals such as Nature is less than 10%, with most manuscripts being rejected at the desk editor stage
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 11:47:08 評論於
Please translate the following paragraph into English and Japanese, with headings as ":" and ":"
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 09:42:34 評論於
How many alternative journals are usually appropriate to choose for each gradient of the journal?
(0) 讚! | 八坂篷蔚

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 20:05:06 評論於
Can I submit directly to top journals like Nature/Science? Will they provide feedback?
(0) 讚! | 龙鳞孝礼

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*